Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$8.75
-0.44-4.79%
At close: Jan 14, 4:00 PM EST
$8.30
-0.89-9.68%
Pre-Market: 7:21 AM EST
Comments
Loading...
PAVmed Analyst Ratings and Price Targets | NASDAQ:PAVM | Benzinga
PAVmed Inc has a consensus price target of $6.63 based on the ratings of 3 analysts. The high is $17 issued by Ascendiant Capital on December 10, 2025. The low is $1.4 issued by Cantor Fitzgerald on August 18, 2023. The 3 most-recent analyst ratings were released by Ascendiant Capital on December 10, 2025, October 6, 2025, and June 6, 2025, respectively. With an average price target of $18.67 between Ascendiant Capital, there's an implied 124.90% upside for PAVmed Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Ascendiant Capital
Cantor Fitzgerald
Lake Street
1calculated from analyst ratings
Analyst Ratings for PAVmed
FAQ
What is the target price for PAVmed (PAVM) stock?
The latest price target for PAVmed (NASDAQ:PAVM) was reported by Ascendiant Capital on December 10, 2025. The analyst firm set a price target for $17.00 expecting PAVM to rise to within 12 months (a possible 104.82% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for PAVmed (PAVM)?
The latest analyst rating for PAVmed (NASDAQ:PAVM) was provided by Ascendiant Capital, and PAVmed maintained their buy rating.
When was the last upgrade for PAVmed (PAVM)?
There is no last upgrade for PAVmed
When was the last downgrade for PAVmed (PAVM)?
The last downgrade for PAVmed Inc happened on January 20, 2023 when Cantor Fitzgerald changed their price target from $4 to $1.5 for PAVmed Inc.
When is the next analyst rating going to be posted or updated for PAVmed (PAVM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PAVmed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PAVmed was filed on December 10, 2025 so you should expect the next rating to be made available sometime around December 10, 2026.
Is the Analyst Rating PAVmed (PAVM) correct?
While ratings are subjective and will change, the latest PAVmed (PAVM) rating was a maintained with a price target of $20.00 to $17.00. The current price PAVmed (PAVM) is trading at is $8.30, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
